Olaplex, a prestige hair care brand, has seen its sales and stock price plummet after a lawsuit. Now, the company is trying to turn its business around.
Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.